Neuralink has announced that it is accepting applications from quadriplegic candidates for the company's first-in-human clinical trials. The trials will see the company implant the N1 brain-computer interface device in the brain of selected candidates using Neuralink's R1 robot to record movement intentions and transmit them to an external device.